NCT05544513View on ClinicalTrials.gov

Oral Iron Supplementation for Patients With Chronic Kidney Disease

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

December 29, 2026

Study Completion Date

December 30, 2026

Conditions
Chronic Renal DiseaseIron-Deficiency AnemiaAnemia of Chronic Kidney DiseaseDysbiosis
Interventions
DRUG

Ferrous sulfate 3 days week

Participants will receive one ferrous sulfate capsule (120 mg of elemental iron) on Mondays, Wednesdays and Fridays

DRUG

Ferrous sulfate daily

Participants will receive one ferrous sulfate (120 mg of elemental iron) capsule daily (except on Sundays)

DRUG

Ferrous sulfate higher concentration

Participants will receive one ferrous sulfate capsule (240mg of elemental iron) on Mondays, Wednesdays and fridays

Trial Locations (1)

22260050

Denise Mafra, Rio de Janeiro

All Listed Sponsors
lead

Universidade Federal Fluminense

OTHER